
    
      The study was an open label, balanced, randomized, two-treatment, two-period, two
      sequence,single dose, crossover, oral bioequivalence study of Ondansetron Hydrochloride
      tablets 8 mg of Dr. Reddy's Laboratories Limited, India comparing with that of ZofranÂ®
      (containing Ondansetron Hydrochloride Dihydrate) tablets 8 mg of GlaxoSmithKline, USA in
      healthy, adult, human subjects under fasting condition. 26 subjects are enrolled in the
      study, and 24 subjects are completed the study.
    
  